T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices

BACKGROUND. A United Network for Organ Sharing policy change in 2015 created a 6-mo delay in the receipt of T2 hepatocellular carcinoma exception points. It was hypothesized that the policy changed locoregional therapy (LRT) practices and explant findings because of longer expected waiting time. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Durkin, Claire, Kaplan, David E., Bittermann, Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447448/
https://www.ncbi.nlm.nih.gov/pubmed/32904026
http://dx.doi.org/10.1097/TXD.0000000000001039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447448/
https://www.ncbi.nlm.nih.gov/pubmed/32904026
http://dx.doi.org/10.1097/TXD.0000000000001039

Ejemplares similares